Email Print

Gibbs to open Greer location in spring


Staff Report
Published Nov. 27, 2012

Spartanburg Regional Healthcare System’s Gibbs Cancer Center plans to open its third site in Greer this spring.

The Gibbs Cancer Center at Pelham will be a 10,000-square-foot, $7 million center on the Village Hospital campus. It will employ up to 20 physicians and offer radiation treatment and oncology medicine.

This expansion will join the medical oncology services that Gibbs Cancer Center’s Palmetto Hematology Oncology has provided in the Greer community since 2006.

Gibbs currently has sites in Spartanburg and Gaffney.

Gibbs Cancer Center also recently appointed Dr. Timothy Yeatman as its director to lead the growth of personalized cancer care in the Upstate.

Previous coverage
Gibbs selected to continue in cancer centers program
Gibbs Cancer Center opens in Gaffney
Spartanburg Regional, St. Francis form oncology partnership

Yeatman created a massive human tumor bio-repository and database with comprehensive molecular profiling of approximately 20,000 tumor specimens, according to a news release. He has helped to deliver personalized cancer care by using this large database to find the right patients for the right drug trials, matching patients through genetic analysis of cancers.

“Dr. Yeatman is a pioneer in personalized medicine, having established the world’s largest human tumor biorepository and database,” said Dr. James Bearden, Gibbs Cancer Center’s managing physician and Spartanburg Regional’s research vice president, in a news release. “Projects like that help us deliver cancer care by matching patients with treatments through genetic analysis of cancers.”

Yeatman most recently worked at Moffitt Cancer Center in Tampa, Fla., where he served as the translational research executive vice president, surgery and oncologic sciences professor and hepatobiliary surgery section head.

“Developing a model for cancer research in Spartanburg will bring the best care to our doorstep,” Spartanburg Regional Healthcare System President and CEO Bruce Holstein said in a news release. “Dr. Yeatman will help us build and refine that model well into the future. Taking these steps now will develop prevention and treatment for us, our children and our grandchildren.”

Yeatman was also the president and founding chief scientific officer of M2Gen, a subsidiary of the Moffitt Cancer Center. Most recently, he was named chief scientific officer for the Center for Advancement of Science in Space, a nonprofit organization appointed by Congress and funded by NASA to oversee all scientific use of the International Space Station.

Yeatman has received numerous honors and awards, such as the James IV Association of Surgeons Traveling Fellowship, Europe; the Center Director’s Award for Outstanding Research at Moffitt Cancer Center; the James Ewing Foundation Trainee Award, Society of Surgical Oncology; and the “Million Dollar Researcher” Award at the University of South Florida.

Yeatman has been continuously funded through grants from the National Cancer Institute and the American Cancer Society. He has published more than 200 articles in top peer-reviewed journals in his field.

Yeatman received his undergraduate degree at Duke University. He received his medical degree from Emory University and completed his surgical internship and residency at the University of Florida, and then a surgical oncology fellowship at MD Anderson Cancer Center, prior to arriving at Moffitt Cancer Center.

Spartanburg Regional’s Gibbs Cancer Center is associated with the National Cancer Institute Community Cancer Center program, the Medical University of South Carolina and the M.D. Anderson Physicians Network.

In June, the cancer center created a partnership with Bon Secours St. Francis Health System to expand oncology services and clinical research in the Upstate.


Comments: